- Home
- CASI vs ISPO Comparison
CASI vs ISPO Comparison
Compare CASI & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- ISPO
- Stock Information
- Founded
- CASI 1991
- ISPO 2010
- Country
- CASI China
- ISPO United States
- Employees
- CASI N/A
- ISPO N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- ISPO Blank Checks
- Sector
- CASI Health Care
- ISPO Finance
- Exchange
- CASI Nasdaq
- ISPO Nasdaq
- Market Cap
- CASI 35.0M
- ISPO 53.5M
- IPO Year
- CASI 1996
- ISPO N/A
- Fundamental
- Price
- CASI $2.21
- ISPO $3.99
- Analyst Decision
- CASI Strong Buy
- ISPO
- Analyst Count
- CASI 1
- ISPO 0
- Target Price
- CASI $6.00
- ISPO N/A
- AVG Volume (30 Days)
- CASI 8.1K
- ISPO 17.9K
- Earning Date
- CASI 03-27-2025
- ISPO 02-24-2025
- Dividend Yield
- CASI N/A
- ISPO N/A
- EPS Growth
- CASI N/A
- ISPO N/A
- EPS
- CASI N/A
- ISPO N/A
- Revenue
- CASI $22,055,000.00
- ISPO $279,855,000.00
- Revenue This Year
- CASI N/A
- ISPO N/A
- Revenue Next Year
- CASI $134.79
- ISPO $127.78
- P/E Ratio
- CASI N/A
- ISPO N/A
- Revenue Growth
- CASI N/A
- ISPO N/A
- 52 Week Low
- CASI $2.04
- ISPO $3.11
- 52 Week High
- CASI $7.67
- ISPO $9.31
- Technical
- Relative Strength Index (RSI)
- CASI 35.91
- ISPO 43.61
- Support Level
- CASI $2.15
- ISPO $3.64
- Resistance Level
- CASI $2.49
- ISPO $4.16
- Average True Range (ATR)
- CASI 0.15
- ISPO 0.33
- MACD
- CASI 0.00
- ISPO -0.02
- Stochastic Oscillator
- CASI 35.42
- ISPO 34.87
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.